These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5082494)

  • 21. The evaluation of present antileprosy compounds.
    Browne SG
    Adv Pharmacol Chemother; 1969; 7():211-51. PubMed ID: 4910168
    [No Abstract]   [Full Text] [Related]  

  • 22. Drugs for leprosy.
    Rees RJ
    Trop Doct; 1973 Apr; 3(2):92-5. PubMed ID: 4691437
    [No Abstract]   [Full Text] [Related]  

  • 23. A new analogous model for the detection and evaluation of chemotherapeutic products effective in leprosy.
    Freerksen E; Rosenfeld M
    Arzneimittelforschung; 1972 Aug; 22(8):1235-42. PubMed ID: 4678384
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of the administration of B663 [G 30 320, Lamprene, clofazimine (Geigy)] on three groups of lepromatous and borderline of leprosy.
    Rodriguez JN; Abalos RM; Reich CV; Tolentino JG
    Int J Lepr Other Mycobact Dis; 1974; 42(3):276-88. PubMed ID: 4617715
    [No Abstract]   [Full Text] [Related]  

  • 25. The drug treatment of leprosy.
    Browne SG
    Practitioner; 1975 Oct; 215(1288):493-500. PubMed ID: 1202470
    [No Abstract]   [Full Text] [Related]  

  • 26. [Activity of B663 in lepromatous leprosy. Therapeutic trial].
    Pene P; Carrie J; Bourgeade A; Bolliot Y
    Bull Soc Pathol Exot Filiales; 1971; 64(4):407-15. PubMed ID: 5172361
    [No Abstract]   [Full Text] [Related]  

  • 27. Chemotherapy in Leprosy.
    Leiker DL
    Int J Dermatol; 1975 May; 14(4):254-62. PubMed ID: 1093982
    [No Abstract]   [Full Text] [Related]  

  • 28. Clofazimine (lamprene or B663) in lepra reactions.
    Imkamp FM
    Lepr Rev; 1981 Jun; 52(2):135-40. PubMed ID: 7242222
    [No Abstract]   [Full Text] [Related]  

  • 29. Leprosy research at the National Institutes of Health: experience with B.663 in the treatment of leprosy.
    Williams TW; Mott PD; Wertlake PT; Rubio JB; Adler RC; Hill GJ; Suarez GP; Knight V
    Int J Lepr; 1965; 33(3):Suppl:767-77. PubMed ID: 5322715
    [No Abstract]   [Full Text] [Related]  

  • 30. Management of steroid-dependency with clofazimine (Lamprene or B 663 (Geigy)).
    Morgan J
    Lepr Rev; 1970 Oct; 41(4):229-32. PubMed ID: 5515679
    [No Abstract]   [Full Text] [Related]  

  • 31. Comments on the chemotherapy of leprosy as influenced by present knowledge of Mycobacterium leprae.
    Pattyn SR
    Lepr Rev; 1973 Sep; 43(3):126-36. PubMed ID: 4120832
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of moderately severe erythema nodosum leprosum with clofazimine--a controlled trial.
    Helmy HS; Pearson JM; Waters MF
    Lepr Rev; 1971 Sep; 42(3):167-77. PubMed ID: 4339652
    [No Abstract]   [Full Text] [Related]  

  • 33. Chemotherapeutic trials in leprosy. 3. Pilot trial of a riminophenazine derivative. B.663, in the treatment of lepromatous leprosy.
    Pettit JH; Rees RJ; Ridley DS
    Int J Lepr Other Mycobact Dis; 1967; 35(1):25-33. PubMed ID: 5336368
    [No Abstract]   [Full Text] [Related]  

  • 34. Clofazimine treatment of cows naturally infected with Mycobacterium paratuberculosis.
    Merkal RS; Larsen AB
    Am J Vet Res; 1973 Jan; 34(1):27-8. PubMed ID: 4683972
    [No Abstract]   [Full Text] [Related]  

  • 35. Controlled long-term therapy of leprosy with B663 (lamprene, clofazimine) compared with DDS.
    Tolentino JG; Rodriquez JN; Abalos RM
    Int J Lepr Other Mycobact Dis; 1974; 42(4):416-418. PubMed ID: 4617720
    [No Abstract]   [Full Text] [Related]  

  • 36. New drug for leprosy.
    Br Med J; 1969 Mar; 1(5647):797-8. PubMed ID: 5774074
    [No Abstract]   [Full Text] [Related]  

  • 37. The control of neuritis in leprosy with clofazimine.
    Pfaltzgraff RE
    Int J Lepr Other Mycobact Dis; 1972; 40(4):392-8. PubMed ID: 4586401
    [No Abstract]   [Full Text] [Related]  

  • 38. A preliminary report on the use of B663 in the treatment of Chinese leprosy patients with chronic reaction.
    Warren AG
    Lepr Rev; 1968 Apr; 39(2):61-6. PubMed ID: 5653308
    [No Abstract]   [Full Text] [Related]  

  • 39. The antileprosy agent B.663 (Clofazimine) and the reticuloendothelial system.
    Conalty ML; Barry VC; Jina A
    Int J Lepr Other Mycobact Dis; 1971; 39(2):479-92. PubMed ID: 4948088
    [No Abstract]   [Full Text] [Related]  

  • 40. Dapsone and sulfapyridine.
    Paniker U; Levine N
    Dermatol Clin; 2001 Jan; 19(1):79-86, viii. PubMed ID: 11155588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.